US ophthalmic product manufacturer Staar Surgical Co said it received approval from China's State Food and Drug Administration (SFDA) to market two more of its implantable lens products.
The Visian toric implantable collamer lens to treat myopia and astigmatism has gained approval, along with the Visian ICH, a lens to correct hyperopia.
The company already markets a myopic implantable lens in China, approved in 2006.
This approval is strategically significant for the company and "positions us for continued ...